Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neutropenia Biologic Drug Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neutropenia Biologic Drug Treatmentmarket, defines the market attractiveness level of Neutropenia Biologic Drug Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neutropenia Biologic Drug Treatment industry, describes the types of Neutropenia Biologic Drug Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neutropenia Biologic Drug Treatment market and the development prospects and opportunities of Neutropenia Biologic Drug Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neutropenia Biologic Drug Treatment market in Chapter 13.
By Player:
Myelo Therapeutics GmbH
Enzychem Lifesciences Corporation
Novartis
Pfizer
Cellerant Therapeutics
CVS Health
Kyowa Kirin
Amgen
Baxter International
Teva Pharmaceutical Industries Ltd
Partner Therapeutics
Dong-A ST CO Ltd
Sanofi
By Type:
Filgrastim
Pegfilgrastim
Lenograstim
Lipegfilgrastim
Sargramostim
By End-User:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neutropenia Biologic Drug Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neutropenia Biologic Drug Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neutropenia Biologic Drug Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neutropenia Biologic Drug Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neutropenia Biologic Drug Treatment Market Analysis and Outlook to 2022
-
7.1 Global Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
7.2 United States Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
7.3 Europe Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
7.4 China Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
7.5 Japan Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
7.6 India Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
7.7 South Korea Neutropenia Biologic Drug Treatment Consumption (2017-2022)
8 Region and Country-wise Neutropenia Biologic Drug Treatment Market Analysis and Outlook to 2028
-
8.1 Global Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
8.2 United States Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
8.4 China Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
8.6 India Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
9 Global Neutropenia Biologic Drug Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Neutropenia Biologic Drug Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Filgrastim Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pegfilgrastim Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lenograstim Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Lipegfilgrastim Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Sargramostim Consumption and Growth Rate (2017-2022)
-
9.2 Global Neutropenia Biologic Drug Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Neutropenia Biologic Drug Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Filgrastim Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lenograstim Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Lipegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Sargramostim Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Neutropenia Biologic Drug Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neutropenia Biologic Drug Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neutropenia Biologic Drug Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neutropenia Biologic Drug Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neutropenia Biologic Drug Treatment Market Competitive Analysis
-
14.1 Myelo Therapeutics GmbH
-
14.1.1 Myelo Therapeutics GmbH Company Details
-
14.1.2 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product and Service
-
14.2 Enzychem Lifesciences Corporation
-
14.2.1 Enzychem Lifesciences Corporation Company Details
-
14.2.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Neutropenia Biologic Drug Treatment Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Neutropenia Biologic Drug Treatment Product and Service
-
14.5 Cellerant Therapeutics
-
14.5.1 Cellerant Therapeutics Company Details
-
14.5.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product and Service
-
14.6 CVS Health
-
14.6.1 CVS Health Company Details
-
14.6.2 CVS Health Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 CVS Health Neutropenia Biologic Drug Treatment Product and Service
-
14.7 Kyowa Kirin
-
14.7.1 Kyowa Kirin Company Details
-
14.7.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Product and Service
-
14.8 Amgen
-
14.8.1 Amgen Company Details
-
14.8.2 Amgen Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Amgen Neutropenia Biologic Drug Treatment Product and Service
-
14.9 Baxter International
-
14.9.1 Baxter International Company Details
-
14.9.2 Baxter International Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Baxter International Neutropenia Biologic Drug Treatment Product and Service
-
14.10 Teva Pharmaceutical Industries Ltd
-
14.10.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.10.2 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Product and Service
-
14.11 Partner Therapeutics
-
14.11.1 Partner Therapeutics Company Details
-
14.11.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Product and Service
-
14.12 Dong-A ST CO Ltd
-
14.12.1 Dong-A ST CO Ltd Company Details
-
14.12.2 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Product and Service
-
14.13 Sanofi
-
14.13.1 Sanofi Company Details
-
14.13.2 Sanofi Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sanofi Neutropenia Biologic Drug Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neutropenia Biologic Drug Treatment
-
Figure Neutropenia Biologic Drug Treatment Picture
-
Table Global Neutropenia Biologic Drug Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neutropenia Biologic Drug Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure United States Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Filgrastim Consumption and Growth Rate (2017-2022)
-
Figure Global Pegfilgrastim Consumption and Growth Rate (2017-2022)
-
Figure Global Lenograstim Consumption and Growth Rate (2017-2022)
-
Figure Global Lipegfilgrastim Consumption and Growth Rate (2017-2022)
-
Figure Global Sargramostim Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Filgrastim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lenograstim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lipegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sargramostim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neutropenia Biologic Drug Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Myelo Therapeutics GmbH (Foundation Year, Company Profile and etc.)
-
Table Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product and Service
-
Table Enzychem Lifesciences Corporation (Foundation Year, Company Profile and etc.)
-
Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Neutropenia Biologic Drug Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neutropenia Biologic Drug Treatment Product and Service
-
Table Cellerant Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product and Service
-
Table CVS Health (Foundation Year, Company Profile and etc.)
-
Table CVS Health Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CVS Health Neutropenia Biologic Drug Treatment Product and Service
-
Table Kyowa Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Kirin Neutropenia Biologic Drug Treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Neutropenia Biologic Drug Treatment Product and Service
-
Table Baxter International (Foundation Year, Company Profile and etc.)
-
Table Baxter International Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Neutropenia Biologic Drug Treatment Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Product and Service
-
Table Partner Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Partner Therapeutics Neutropenia Biologic Drug Treatment Product and Service
-
Table Dong-A ST CO Ltd (Foundation Year, Company Profile and etc.)
-
Table Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Neutropenia Biologic Drug Treatment Product and Service
-
